These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20419525)

  • 21. Relapse prevention and selective serotonin reuptake inhibitor medication in two adolescents with anorexia nervosa.
    Luzier J; Rached K; Talley J
    Int J Eat Disord; 2019 Jul; 52(7):863-867. PubMed ID: 31081553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
    Strobel M; Warnke A; Roth M; Schulze U
    Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
    Bissada H; Tasca GA; Barber AM; Bradwejn J
    Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
    Kafantaris V; Leigh E; Hertz S; Berest A; Schebendach J; Sterling WM; Saito E; Sunday S; Higdon C; Golden NH; Malhotra AK
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder.
    Nagata T; Ono K; Nakayama K
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):434-6. PubMed ID: 17610670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors in anorexia nervosa.
    Bergh C; Eriksson M; Lindberg G; Södersten P
    Lancet; 1997 Oct; 350(9083):1033-4. PubMed ID: 9329540
    [No Abstract]   [Full Text] [Related]  

  • 27. Case reports of olanzapine treatment of anorexia nervosa.
    La Via MC; Gray N; Kaye WH
    Int J Eat Disord; 2000 Apr; 27(3):363-6. PubMed ID: 10694725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion?
    Brambilla F; Monteleone P; Maj M
    Psychoneuroendocrinology; 2007 May; 32(4):402-6. PubMed ID: 17395395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine versus placebo for out-patients with anorexia nervosa.
    Attia E; Kaplan AS; Walsh BT; Gershkovich M; Yilmaz Z; Musante D; Wang Y
    Psychol Med; 2011 Oct; 41(10):2177-82. PubMed ID: 21426603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotics as augmentation therapy in anorexia nervosa.
    Marzola E; Desedime N; Giovannone C; Amianto F; Fassino S; Abbate-Daga G
    PLoS One; 2015; 10(4):e0125569. PubMed ID: 25922939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citalopram in anorexia nervosa.
    Pallanti S; Quercioli L; Ramacciotti A
    Eat Weight Disord; 1997 Dec; 2(4):216-21. PubMed ID: 14655831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotropic Medication for Children and Adolescents with Eating Disorders.
    Couturier J; Isserlin L; Spettigue W; Norris M
    Child Adolesc Psychiatr Clin N Am; 2019 Oct; 28(4):583-592. PubMed ID: 31443877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.
    Walsh BT; Kaplan AS; Attia E; Olmsted M; Parides M; Carter JC; Pike KM; Devlin MJ; Woodside B; Roberto CA; Rockert W
    JAMA; 2006 Jun; 295(22):2605-12. PubMed ID: 16772623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of fluoxetine in anorexia nervosa before and after weight restoration.
    Sebaaly JC; Cox S; Hughes CM; Kennedy ML; Garris SS
    Ann Pharmacother; 2013 Sep; 47(9):1201-5. PubMed ID: 24259736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine-induced hypoglycemia in anorexia nervosa.
    Haruta I; Asakawa A; Inui A
    Endocrine; 2014 Aug; 46(3):672-3. PubMed ID: 24659174
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.
    Krüger S; Kennedy SH
    J Psychiatry Neurosci; 2000 Nov; 25(5):497-508. PubMed ID: 11109300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does percent body fat predict outcome in anorexia nervosa?
    Mayer LE; Roberto CA; Glasofer DR; Etu SF; Gallagher D; Wang J; Heymsfield SB; Pierson RN; Attia E; Devlin MJ; Walsh BT
    Am J Psychiatry; 2007 Jun; 164(6):970-2. PubMed ID: 17541059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.
    Mondraty N; Birmingham CL; Touyz S; Sundakov V; Chapman L; Beumont P
    Australas Psychiatry; 2005 Mar; 13(1):72-5. PubMed ID: 15777417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine for treatment of anorexia nervosa.
    Dettling M; Opgen-Rhein C; Quante A; Anghelescu I
    JAMA; 2006 Nov; 296(20):2439-40; author reply 2440. PubMed ID: 17119138
    [No Abstract]   [Full Text] [Related]  

  • 40. Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?
    Ferguson CP; La Via MC; Crossan PJ; Kaye WH
    Int J Eat Disord; 1999 Jan; 25(1):11-7. PubMed ID: 9924648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.